Novel CRTH2 antagonists: a review of patents from 2006 to 2009
Research output: Contribution to journal › Journal article › Research › peer-review
The receptor CRTH2 (also known as DP₂) is an important mediator of the inflammatory effects of prostaglandin D₂ and has attracted much attention as a therapeutic target for the treatment of conditions such as asthma, COPD, allergic rhinitis and atopic dermatitis.
| Original language | English |
|---|---|
| Journal | Expert Opinion on Therapeutic Patents |
| Volume | 20 |
| Issue number | 11 |
| Pages (from-to) | 1505-1530 |
| Number of pages | 26 |
| ISSN | 1354-3776 |
| DOIs | |
| Publication status | Published - 1 Nov 2010 |
ID: 189162560